期刊
JOURNAL OF CLINICAL MICROBIOLOGY
卷 55, 期 9, 页码 2599-2608出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/JCM.00635-17
关键词
clinical microbiology; endocarditis
类别
资金
- BioFire
- Check-Points
- Curetis
- 3M
- Merck
- Hutchison Biofilm Medical Solutions
- Accelerate Diagnostics
- Allergan
- The Medicines Company
- ASM
- IDSA
- Samsung
Infective endocarditis is life-threatening; identification of the underlying etiology informs optimized individual patient management. Changing epidemiology, advances in blood culture techniques, and new diagnostics guide the application of laboratory testing for diagnosis of endocarditis. Blood cultures remain the standard test for microbial diagnosis, with directed serological testing (i.e., Q fever serology, Bartonella serology) in culture-negative cases. Histopathology and molecular diagnostics (e.g., 16S rRNA gene PCR/sequencing, Tropheryma whipplei PCR) may be applied to resected valves to aid in diagnosis. Herein, we summarize recent knowledge in this area and propose a microbiologic and pathological algorithm for endocarditis diagnosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据